西南国防医药
西南國防醫藥
서남국방의약
MEDICAL JOURNAL OF NATIONAL DEFENDING FORCES IN SOUTHWEST CHINA
2014年
10期
1060-1062
,共3页
段享梅%王铁荣%陈芳%项波%孔繁敏
段享梅%王鐵榮%陳芳%項波%孔繁敏
단향매%왕철영%진방%항파%공번민
有机磷农药%中毒%血液灌流%血液透析%成本效果
有機燐農藥%中毒%血液灌流%血液透析%成本效果
유궤린농약%중독%혈액관류%혈액투석%성본효과
organophosphorus pesticide%poisoning%hemoperfusion%hemodialysis%cost effectiveness
目的:对组合型血液净化治疗重度有机磷农药中毒进行疗效观察,探讨其成本效果。方法遵循临床流行病学与卫生经济学的原理和方法,选择43例接受组合型血液净化治疗的重度有机磷农药中毒患者(治疗组),与常规内科综合救治的重度有机磷农药中毒患者(对照组)进行对比,记录临床疗效和费用,比较两组的成本效果。结果两组的成本效果比(C/ E)分别为7636和9259,在达到相同康复率时,治疗组比对照组节省1623元,所需医疗费用仅为对照组的82.5%;以对照组为基准,增量成本效果比为1269.2,治疗组每增加1%的康复率,仅比对照组多用12.69元。结论组合型血液净化治疗重度有机磷农药中毒在抢救成功率、治疗成本等方面均令人满意,值得在临床上推广应用。
目的:對組閤型血液淨化治療重度有機燐農藥中毒進行療效觀察,探討其成本效果。方法遵循臨床流行病學與衛生經濟學的原理和方法,選擇43例接受組閤型血液淨化治療的重度有機燐農藥中毒患者(治療組),與常規內科綜閤救治的重度有機燐農藥中毒患者(對照組)進行對比,記錄臨床療效和費用,比較兩組的成本效果。結果兩組的成本效果比(C/ E)分彆為7636和9259,在達到相同康複率時,治療組比對照組節省1623元,所需醫療費用僅為對照組的82.5%;以對照組為基準,增量成本效果比為1269.2,治療組每增加1%的康複率,僅比對照組多用12.69元。結論組閤型血液淨化治療重度有機燐農藥中毒在搶救成功率、治療成本等方麵均令人滿意,值得在臨床上推廣應用。
목적:대조합형혈액정화치료중도유궤린농약중독진행료효관찰,탐토기성본효과。방법준순림상류행병학여위생경제학적원리화방법,선택43례접수조합형혈액정화치료적중도유궤린농약중독환자(치료조),여상규내과종합구치적중도유궤린농약중독환자(대조조)진행대비,기록림상료효화비용,비교량조적성본효과。결과량조적성본효과비(C/ E)분별위7636화9259,재체도상동강복솔시,치료조비대조조절성1623원,소수의료비용부위대조조적82.5%;이대조조위기준,증량성본효과비위1269.2,치료조매증가1%적강복솔,부비대조조다용12.69원。결론조합형혈액정화치료중도유궤린농약중독재창구성공솔、치료성본등방면균령인만의,치득재림상상추엄응용。
Objective To observe the curative effects of combined blood purification for treatment of severe organophosphorus pesticide poisoning(SOPP)and calculate its cost effectiveness. Methods Total 43 SOPP patients who were treated with combined blood purification(the treatment group)were selected and compared with other SOPP ones who received the conventional comprehensive treatment(the control group). According to the principles and methods of clinical epidemiology and health economics,the clinical effects and health care costs were recorded and the cost effectiveness was compared between the two groups. Results The cost effectiveness (C/ E)of the two groups was 7636 and 9259,respectively. With the same recovery rate,the treatment group saved ¥1623 compared with the control group,and the required medical expense was only 82. 5% of that of the control group. When the control group was taken as a reference,the cost effectiveness increment was 1269.2, i. e. , the treatment group used only ¥12.69 more than the control group for every 1% of the increased recovery rate. Conclusion Whether the success rate of rescue or treatment cost,combined blood purification for treatment of SOPP is satisfactory and it is worthy in clinical use.